Integra LifeSciences (IART) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Integra LifeSciences Reports Third Quarter 2016 Financial Results
October 27, 2016 4:02 PM EDTRevenue Increased 10.6% to $250.3 million; Organic Revenue Increased 9.5%
 Reported EPS of $0.50; Adjusted EPS of $0.93
PLAINSBORO, N.J., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported its financial results for the third quarter ending September 30, 2016.
Highlights:
Third quarter revenue increased 10.6% over the prior-year quarter to $250.3 million, and... More